Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID06585033

Spinal Cord Stimulation for Therapy-Resistant Neuropathic Pain After Lumbar Spinal Surgery A Randomized, Double-Blind, Sham-Controlled, Cross-over Study

Led by Sahlgrenska University Hospital · Updated on 2025-12-02

50

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Sahlgrenska University Hospital

Lead Sponsor

R

Rijnstate Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating spinal cord stimulation (SCS) as a treatment for persistent neuropathic leg pain that continues after lumbar spinal surgery and does not improve with medication or other conservative treatments. This study is a multicenter, double-blind, randomized, sham-controlled trial designed to compare the long-term effects of active, subthreshold SCS versus no stimulation (placebo) on reducing neuropathic leg pain in patients with persistent spinal pain syndrome type 2 (PSPS2). The study aims to assess not only pain reduction but also quality of life, physical functioning, sleep quality, return to work, and medication use. Participants who respond positively to a two-week SCS test trial will have a non-rechargeable Boston Alpha Prime SCS system implanted. After initial electrode implantation and a trial phase, those with adequate pain relief will receive a permanent implant. The study includes a four-week optimization period followed by a six-month randomized crossover phase where patients receive either active subthreshold stimulation or sham stimulation for three months each. Then, participants will use their preferred stimulation form for an additional six months. Both patients and physicians remain unaware of the stimulation status during the blinded phases, with only a research nurse managing programming. During the study, participants will complete questionnaires before implantation and at regular follow-ups at 3, 6, and 12 months. Researchers will monitor changes in leg pain intensity using the Numeric Rating Scale (NRS) and evaluate secondary outcomes such as quality of life and physical function. After completing the 12-month follow-up, blinding will be lifted, and participants may choose any available stimulation form. The total participation duration is approximately one year, including surgery, stimulation phases, and follow-up assessments.

CONDITIONS

Brief Title

Placebo Effect In Spinal Cord Electrical Stimulation for Pain

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • History consistent with persistent spinal pain syndrome type 2 (PSPS2) lasting at least 6 months after last spinal surgery
  • Patients aged between 18 and 70 years
  • Average leg pain intensity of 5 or more and back pain less than 3 on the Numeric Rating Scale (0-10)
  • Provided informed written consent after verbal and written study information
  • Achieved at least 50% pain relief during a 2-week active spinal cord stimulation test trial
Not Eligible

You will not qualify if you...

  • Unable to understand or operate the spinal cord stimulation device
  • Currently have an active implantable device such as pacemaker or intrathecal drug delivery system
  • Have an ongoing coagulation disorder
  • Abuse of alcohol, drugs, or prescription opioids
  • Active debilitating psychiatric illness
  • Active malignancy
  • Condition causing increased infection risk, such as immunodeficiency
  • Expected lifespan less than 1 year
  • Ongoing local infection or skin disease where the implantable pulse generator is planned
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Surgery

Duration - Initial surgery and recovery period

Participants undergo surgery to implant electrode(s) into the epidural space for spinal cord stimulation.

1 surgical visit plus recovery period

Run-in Period

Duration - 2 weeks

Participants undergo a 2-week trial phase with external stimulation to determine if adequate pain relief is achieved.

Trial phase with external device; visits not specifically detailed

Surgery

Duration - Permanent implant surgery and recovery

Participants who respond positively to the trial phase receive implantation of a permanent pulse generator under the skin.

1 surgical visit plus recovery period

Treatment

Duration - 12 months

Participants receive either active subthreshold spinal cord stimulation or sham stimulation in a double-blind, randomized crossover design with a 4-week optimization period followed by two 3-month stimulation periods and a final 6-month period using the preferred stimulation.

Routine follow-up visits at 3, 6, and 12 months

Trial Site Locations

Total: 4 locations

1

Department of Anaesthesiology and Pain Management, Rijnstate Hospital

Arnhem, Netherlands, 6800

Actively Recruiting

2

Department of Neurosurgery, Stavanger University hospital

Stavanger, Norway, 4019

Actively Recruiting

3

Department of Neurosurgery, Sahlgrenska University Hospital

Gothenburg, Sweden, 41257

Actively Recruiting

4

Department of Anesthesiology and Intensive Care/Pain Center, Sahlgrenska University Hospital Östra

Gothenburg, Sweden, 41650

Actively Recruiting

Loading map...

Research Team

K

Kliment Gatzinsky, MD, PhD

J

Jan Willem Kallewaard, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Comparative Effect of Echogenic Needle for Nerve Block on ...

Chronic Postoperative Pain

Actively Recruiting

1 location

A Comparative Evaluation of Intravenous Analgesia, Thoracic ...

Chronic Postoperative Pain

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.

Timothy R Deer, Nagy Mekhail, David Provenzano...

https://pubmed.ncbi.nlm.nih.gov/25112889

Neurostimulation for Chronic Pain: A Systematic Review of High-Quality Randomized Controlled Trials With Long-Term Follow-Up.

Yilong Zheng, Christopher Weiyang Liu, Diana Xin Hui Chan...

https://pubmed.ncbi.nlm.nih.gov/37436342

Treatment Options for Failed Back Surgery Syndrome Patients With Refractory Chronic Pain: An Evidence Based Approach.

Kasra Amirdelfan, Lynn Webster, Lawrence Poree...

https://pubmed.ncbi.nlm.nih.gov/28505029

Optimizing the Management and Outcomes of Failed Back Surgery Syndrome: A Consensus Statement on Definition and Outlines for Patient Assessment.

Philippe Rigoard, Kliment Gatzinsky, Jean-Philippe Deneuville...

https://pubmed.ncbi.nlm.nih.gov/30911339

Optimizing the Management and Outcomes of Failed Back Surgery Syndrome: A Proposal of a Standardized Multidisciplinary Team Care Pathway.

Kliment Gatzinsky, Sam Eldabe, Jean-Philippe Deneuville...

https://pubmed.ncbi.nlm.nih.gov/31360272

Incidence of Low Back Pain After Lumbar Discectomy for Herniated Disc and Its Effect on Patient-reported Outcomes.

Scott L Parker, Stephen K Mendenhall, Saniya S Godil...

https://pubmed.ncbi.nlm.nih.gov/25694267

The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).

Sharada Weir, Mihail Samnaliev, Tzu-Chun Kuo...

https://pubmed.ncbi.nlm.nih.gov/28893756

Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial.

Leonardo Kapural, Cong Yu, Matthew W Doust...

https://pubmed.ncbi.nlm.nih.gov/26218762

Spinal Cord Stimulation (SCS) with Anatomically Guided (3D) Neural Targeting Shows Superior Chronic Axial Low Back Pain Relief Compared to Traditional SCS-LUMINA Study.

Elias Veizi, Salim M Hayek, James North...

https://pubmed.ncbi.nlm.nih.gov/28108641